These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1033 related articles for article (PubMed ID: 28710827)

  • 141. Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling.
    Abilez OJ; Tzatzalos E; Yang H; Zhao MT; Jung G; Zöllner AM; Tiburcy M; Riegler J; Matsa E; Shukla P; Zhuge Y; Chour T; Chen VC; Burridge PW; Karakikes I; Kuhl E; Bernstein D; Couture LA; Gold JD; Zimmermann WH; Wu JC
    Stem Cells; 2018 Feb; 36(2):265-277. PubMed ID: 29086457
    [TBL] [Abstract][Full Text] [Related]  

  • 142. Morpho-functional comparison of differentiation protocols to create iPSC-derived cardiomyocytes.
    Nijak A; Simons E; Vandendriessche B; Van de Sande D; Fransen E; Sieliwończyk E; Van Gucht I; Van Craenenbroeck E; Saenen J; Heidbuchel H; Ponsaerts P; Labro AJ; Snyders D; De Vos W; Schepers D; Alaerts M; Loeys BL
    Biol Open; 2022 Feb; 11(2):. PubMed ID: 35195246
    [TBL] [Abstract][Full Text] [Related]  

  • 143. Exosomes: Beyond stem cells for cardiac protection and repair.
    Balbi C; Vassalli G
    Stem Cells; 2020 Nov; 38(11):1387-1399. PubMed ID: 32761640
    [TBL] [Abstract][Full Text] [Related]  

  • 144. Nuclear transcriptome profiling of induced pluripotent stem cells and embryonic stem cells identify non-coding loci resistant to reprogramming.
    Fort A; Yamada D; Hashimoto K; Koseki H; Carninci P
    Cell Cycle; 2015; 14(8):1148-55. PubMed ID: 25664506
    [TBL] [Abstract][Full Text] [Related]  

  • 145. Metabolic Maturation Increases Susceptibility to Hypoxia-induced Damage in Human iPSC-derived Cardiomyocytes.
    Peters MC; Maas RGC; van Adrichem I; Doevendans PAM; Mercola M; Šarić T; Buikema JW; van Mil A; Chamuleau SAJ; Sluijter JPG; Hnatiuk AP; Neef K
    Stem Cells Transl Med; 2022 Oct; 11(10):1040-1051. PubMed ID: 36018047
    [TBL] [Abstract][Full Text] [Related]  

  • 146. Regenerative potential of mouse embryonic stem cell-derived PDGFRα
    Hong SP; Song S; Lee S; Jo H; Kim HK; Han J; Park JH; Cho SW
    World J Stem Cells; 2019 Jan; 11(1):44-54. PubMed ID: 30705714
    [TBL] [Abstract][Full Text] [Related]  

  • 147. Apela Promotes Cardiomyocyte Differentiation from Transgenic Human Embryonic Stem Cell Lines.
    Wang Z; Huang J
    Appl Biochem Biotechnol; 2019 Oct; 189(2):396-410. PubMed ID: 31025171
    [TBL] [Abstract][Full Text] [Related]  

  • 148. Synthetic sulfonyl-hydrazone-1 positively regulates cardiomyogenic microRNA expression and cardiomyocyte differentiation of induced pluripotent stem cells.
    Quattrocelli M; Palazzolo G; Agnolin I; Martino S; Bouché M; Anastasia L; Sampaolesi M
    J Cell Biochem; 2011 Aug; 112(8):2006-14. PubMed ID: 21445862
    [TBL] [Abstract][Full Text] [Related]  

  • 149. Overexpression of Kir2.1 channel in embryonic stem cell-derived cardiomyocytes attenuates posttransplantation proarrhythmic risk in myocardial infarction.
    Liao SY; Tse HF; Chan YC; Mei-Chu Yip P; Zhang Y; Liu Y; Li RA
    Heart Rhythm; 2013 Feb; 10(2):273-82. PubMed ID: 23041574
    [TBL] [Abstract][Full Text] [Related]  

  • 150. Derivation and high engraftment of patient-specific cardiomyocyte sheet using induced pluripotent stem cells generated from adult cardiac fibroblast.
    Zhang L; Guo J; Zhang P; Xiong Q; Wu SC; Xia L; Roy SS; Tolar J; O'Connell TD; Kyba M; Liao K; Zhang J
    Circ Heart Fail; 2015 Jan; 8(1):156-66. PubMed ID: 25420485
    [TBL] [Abstract][Full Text] [Related]  

  • 151. Characterization of cardiac metabolism in iPSC-derived cardiomyocytes: lessons from maturation and disease modeling.
    Vučković S; Dinani R; Nollet EE; Kuster DWD; Buikema JW; Houtkooper RH; Nabben M; van der Velden J; Goversen B
    Stem Cell Res Ther; 2022 Jul; 13(1):332. PubMed ID: 35870954
    [TBL] [Abstract][Full Text] [Related]  

  • 152. Pivotal Role of Non-cardiomyocytes in Electromechanical and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissue.
    Iseoka H; Miyagawa S; Fukushima S; Saito A; Masuda S; Yajima S; Ito E; Sougawa N; Takeda M; Harada A; Lee JK; Sawa Y
    Tissue Eng Part A; 2018 Feb; 24(3-4):287-300. PubMed ID: 28498040
    [TBL] [Abstract][Full Text] [Related]  

  • 153. Molecular Profiling of Human Induced Pluripotent Stem Cell-Derived Cells and their Application for Drug Safety Study.
    Matsui T; Miyamoto N; Saito F; Shinozawa T
    Curr Pharm Biotechnol; 2020; 21(9):807-828. PubMed ID: 32321398
    [TBL] [Abstract][Full Text] [Related]  

  • 154. Elimination of residual undifferentiated induced pluripotent stem cells (iPSCs) using irradiation for safe clinical applications of iPSC-derived cardiomyocytes.
    Takeda M; Ito E; Minami K; Harada A; Mochizuki-Oda N; Sawa Y; Miyagawa S
    Biochem Biophys Res Commun; 2021 Oct; 574():91-96. PubMed ID: 34450429
    [TBL] [Abstract][Full Text] [Related]  

  • 155. Interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue.
    Song H; Yoon C; Kattman SJ; Dengler J; Massé S; Thavaratnam T; Gewarges M; Nanthakumar K; Rubart M; Keller GM; Radisic M; Zandstra PW
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3329-34. PubMed ID: 19846783
    [TBL] [Abstract][Full Text] [Related]  

  • 156. Production of functional cardiomyocytes and cardiac tissue from human induced pluripotent stem cells for regenerative therapy.
    Tani H; Tohyama S; Kishino Y; Kanazawa H; Fukuda K
    J Mol Cell Cardiol; 2022 Mar; 164():83-91. PubMed ID: 34822838
    [TBL] [Abstract][Full Text] [Related]  

  • 157. Assessment of temporal functional changes and miRNA profiling of human iPSC-derived cardiomyocytes.
    Kumar N; Dougherty JA; Manring HR; Elmadbouh I; Mergaye M; Czirok A; Greta Isai D; Belevych AE; Yu L; Janssen PML; Fadda P; Gyorke S; Ackermann MA; Angelos MG; Khan M
    Sci Rep; 2019 Sep; 9(1):13188. PubMed ID: 31515494
    [TBL] [Abstract][Full Text] [Related]  

  • 158. Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells.
    Li J; Feng X; Wei X
    Stem Cell Res Ther; 2022 Jun; 13(1):232. PubMed ID: 35659761
    [TBL] [Abstract][Full Text] [Related]  

  • 159. Longitudinal metabolic profiling of cardiomyocytes derived from human-induced pluripotent stem cells.
    Bekhite MM; González Delgado A; Menz F; Kretzschmar T; Wu JMF; Bekfani T; Nietzsche S; Wartenberg M; Westermann M; Greber B; Schulze PC
    Basic Res Cardiol; 2020 May; 115(4):37. PubMed ID: 32424548
    [TBL] [Abstract][Full Text] [Related]  

  • 160. Progress in the Use of Induced Pluripotent Stem Cell-Derived Neural Cells for Traumatic Spinal Cord Injuries in Animal Populations: Meta-Analysis and Review.
    Ramotowski C; Qu X; Villa-Diaz LG
    Stem Cells Transl Med; 2019 Jul; 8(7):681-693. PubMed ID: 30903654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.